Page 1 of 2 LRC 2025-BR1519-SB128
COMMONWEALTH OF KENTUCKY FISCAL NOTE STATEMENT
LEGISLATIVE RESEARCH COMMISSION
2025 REGULAR SESSION
MEASURE
2025 BR NUMBER 1519 SENATE BILL NUMBER 128
TITLE AN ACT relating to utilization controls for nonopioid analgesics in the Medicaid program.
SPONSOR Senator Gerald Neal
FISCAL SUMMARY
STATE FISCAL IMPACT: YES NO UNCERTAIN
OTHER FISCAL STATEMENT (S) THAT MAY APPLY: ACTUARIAL ANALYSIS
LOCAL MANDATE CORRECTIONS IMPACT HEALTH BENEFIT MANDATE STATE
EMPLOYEE HEALTH PLAN IMPACT
APPROPRIATION UNIT(S) IMPACTED:
FUND(S) IMPACTED: GENERAL ROAD FEDERAL RESTRICTED
FISCAL ESTIMATES 2024-2025 2025-2026 ANNUAL IMPACT AT FULL
IMPLEMENTATION
REVENUES
EXPENDITURES
NET EFFECT
( ) indicates a decrease/negative
PURPOSE OF MEASURE: The measure prohibits the denial of coverage or the establishment
of more restrictive or extensive utilization controls for nonopioid analgesics as compared to
opioid or narcotic analgesics by the Department for Medicaid Services (DMS), any Medicaid
managed care organization contracted by the DMS, and the Medicaid state pharmacy benefit
manager.
FISCAL EXPLANATION : The Cabinet for Health and Family Services estimates that Senate
Bill 128 will not have a fiscal impact on the Department for Medicaid Services.
DATA SOURCE(S): Cabinet for Health and Family Services
PREPARER: Miriam Fordham NOTE NUMBER: 98 REVIEW: JMR DATE: 2/24/2025
Page 2 of 2 LRC 2025-BR1519-SB128